Characterisation of Anti-HBs Responses in Patients Undergoing Functional Hepatitis B Cure: Implication for Future Therapies [ 2017 - ]

Research Grant

Researchers: Prof Stephen Locarnini (Principal investigator) ,  Dr Gregor Ebert ,  Dr Renae Walsh ,  Prof Alexander Thompson ,  Prof Hans Netter

Brief description The hepatitis B virus causes liver cirrhosis and liver cancer. There is no cure for hepatitis B. However, a small number of patients can naturally rid themselves of the virus. We have identified 14 of these individuals and discovered that they have a unique immune response that is responsible for these “natural” cures. We plan to characterise this immune response and turn it into a therapeutic vaccine which can be used to cure patients who are still chronically infected.

Funding Amount $723,649.00

Funding Scheme Project Grants

Notes Standard Project Grant